Diabetes and risk of infections with immunomodulator therapy in inflammatory bowel diseases

BACKGROUND: Infections are an important concern in patients using immunosuppressive therapy for their inflammatory bowel disease (IBD). Diabetes affects nearly 10% of Americans. Whether it confers an additional risk with immunosuppression in IBD has not been examined previously. AIM: To examine the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Aliment Pharmacol Ther
Main Authors: Ananthakrishnan, Ashwin N., Cagan, Andrew, Cai, Tianxi, Gainer, Vivian S., Shaw, Stanley Y, Churchill, Susanne, Karlson, Elizabeth W., Murphy, Shawn N., Kohane, Isaac, Liao, Katherine P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4420684/
https://ncbi.nlm.nih.gov/pubmed/25864945
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.13195
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados